Lannett Company Inc.: Niacin Extended-release Tablets, Usp, 1,000 Mg, 90-count Bottles
Recall Summary Lannett Company is recalling niacin extended-release 1,000 mg tablets (90-count bottles) distributed nationwide because the medication failed to dissolve properly during stability testing, which could affect how the body absorbs the drug. This is a Class II recall, meaning the product could cause serious health consequences or adverse effects. The recall affects all U.S. states and Washington, D.C.
- Recalling firm
- Lannett Company Inc.
- Product
- Niacin Extended-release Tablets, USP, 1,000 mg, 90-count bottles, Rx Only, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC 62175-322-46.
- Reason
- Failed Dissolution Specifications: during 12M LT stability testing OOS low for Stage 3 dissolution at the 24-hour timepoint.
- Classification
- Class II
- Category
- drug recall
- Country
- United States
- Agency
- U.S. Food and Drug Administration
- Recall date
- 2026-05-27
- Status
- Ongoing
- Areas affected
- AL, AK, AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, ...
- Distribution
- Nationwide within the United States
Official recall notice from U.S. Food and Drug Administration
Recall details on Nibble Recalls: https://trynibble.app/recalls/39839568-bc26-41d1-be21-b26da6085da9